Future Considerations. It is anticipated by Histogenics and ABM that there may be a need to expand the use and deployment of the Technology in the future, depending upon the development of the Histogenics business. These expansions will be negotiated diligently by the parties, acting reasonably and in good faith and this agreement will be appropriately amended in the future to address such future needs.
Appears in 2 contracts
Sources: Collagen Technology Transfer Agreement, Collagen Technology Transfer Agreement (Histogenics Corp)